Compagnie Lombard Odier SCmA’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.24K Hold
618
– – ﹤0.01% 434
2026
Q1
$3.37K Hold
618
– – ﹤0.01% 404
2025
Q4
$4.33K Hold
618
– – ﹤0.01% 398
2025
Q3
$4.78K Hold
618
– – ﹤0.01% 417
2025
Q2
$5.38K Hold
618
– – ﹤0.01% 402
2025
Q1
$4.92K Hold
618
– – ﹤0.01% 440
2024
Q4
$5.62K Hold
618
– – ﹤0.01% 419
2024
Q3
$5.67K Sell
618
-40
-6% -$331 ﹤0.01% 415
2024
Q2
$6.43K Hold
658
– – ﹤0.01% 405
2024
Q1
$9.94K Hold
658
– – ﹤0.01% 426
2023
Q4
$14.2K Sell
658
-78
-11% -$1.44K ﹤0.01% 478
2023
Q3
$13.7K Sell
736
-2,660
-78% -$62.1K ﹤0.01% 505
2023
Q2
$86K Buy
3,396
+590
+21% +$14.8K ﹤0.01% 366
2023
Q1
$72.7K Hold
2,806
– – ﹤0.01% 407
2022
Q4
$67K Hold
2,806
– – ﹤0.01% 441
2022
Q3
$70K Sell
2,806
-1,220
-30% -$42.8K ﹤0.01% 432
2022
Q2
$135K Sell
4,026
-77
-2% -$3.27K ﹤0.01% 346
2022
Q1
$298K Buy
4,103
+500
+14% +$36K 0.01% 263
2021
Q4
$331K Buy
3,603
+178
+5% +$21.3K 0.01% 296
2021
Q3
$435K Sell
3,425
-400
-10% -$58.2K 0.01% 256
2021
Q2
$638K Sell
3,825
-35,553
-90% -$5.76M 0.01% 203
2021
Q1
$7.16M Buy
39,378
+38,713
+5,822% +$8.98M 0.16% 96
2020
Q4
$133K Buy
665
+588
+764% +$120K ﹤0.01% 365
2020
Q3
$17K Buy
+77
New +$16.3K ﹤0.01% 457
2019
Q1
– Sell
-625
Closed -$38.2K – 605
2018
Q4
$31K Buy
+625
New +$38.2K ﹤0.01% 419

Other funds holding TDOC

Compagnie Lombard Odier SCmA's TDOC Position: Q2 2026 in Review

Compagnie Lombard Odier SCmA held its Teladoc Health (TDOC) position steady in Q2 2026 at 618 shares worth $5.24K. The position accounts for ﹤0.01% of the portfolio, ranked #434.

Compagnie Lombard Odier SCmA first reported a position in TDOC in Q4 2018 and has held it in 25 quarters since. The position peaked at $7.16M in Q1 2021. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Compagnie Lombard Odier SCmA held 618 shares of Teladoc Health worth $5.24K as of Q2 2026.
  • Compagnie Lombard Odier SCmA left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Compagnie Lombard Odier SCmA's portfolio in Q2 2026, its #434 holding.
  • Compagnie Lombard Odier SCmA first reported a position in Teladoc Health in Q4 2018 and has held it in 25 quarters since.
  • Compagnie Lombard Odier SCmA's Teladoc Health position peaked at $7.16M in Q1 2021.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2026, filed 29 Jul 2026.